Cambridge, UK ; New York : Cambridge University Press, 2001.
Book — xiii, 282 p. : ill. ; 24 cm.
Acknowledgements-- Abbreviations-- Introduction-- Part I. Agents:
1. Cancer chemotherapy: plant knowledge and practice-- Part II. Practices:
2. Act I: 1962-1975--
3. Act II: 1976-1983--
4. Act III: 1984-1989-- Part III. Controversies:
5. The politics of exclusivity and the business of taxol--
6. The political life (and death) of Taxus Brevifolia-- References and bibliography-- Index.
(source: Nielsen Book Data)
Taxol is arguably the most celebrated, talked-about and controversial natural product in recent years. It is celebrated because of its efficacy as an anti-cancer drug and because its discovery has provided powerful support for policies concerned with biodiversity; talked about because in the late 1980s and early 1990s the American public was bombarded with news reports and special programmes about the molecule and its host, the Pacific yew; and controversial because during the early 1990s the drug and the tree became embroiled in a number of very sensitive political issues with wide implications for the conduct of public policy. The Story of Taxol tells this story. (source: Nielsen Book Data)